Le Lézard
Classified in: Health, Science and technology
Subject: TDS

Fovia Ai to Showcase AI Visualization Integrations at IAIP Exhibit, RSNA 2021


CHICAGO, Nov. 28, 2021 /PRNewswire/ -- Fovia Ai, Inc., a subsidiary of Fovia, Inc., a world leader in advanced visualization for nearly two decades and a preeminent provider of zero-footprint, cloud-based imaging SDKs, today announced that it will be showcasing visualization, navigation and seamless integrations of AI in the Imaging Artificial Intelligence in Practice (IAIP) demonstration being held November 28 ? December 1 at the 107th Scientific Assembly and Annual Meeting of the Radiology Society of North America (RSNA 2021) at McCormick Place in Chicago.

RSNA attendees visiting the IAIP exhibit will be able to explore meaningful AI integrations from 22 exhibitors based on real-world clinical scenarios and will see live demonstrations of Fovia Ai software integrated with vendors including Siemens Healthineers, 3M M*Modal, Ambra Health, Bayer AI, Lunit, Smart Reporting and VUNO. The interactive exhibit provides attendees access to emerging AI technologies, demonstrates the interoperability standards needed to integrate into the workflow of diagnostic radiology, and highlights AI-driven products that remove barriers to clinical adoption.

"Fovia is proud to join the IAIP emphasizing interoperability. It has been enlightening to work with the other vendors to connect many disparate AI products in a real-world, clinical scenario. We are pleased that the existence of standards such as FHIR, DICOMweb/WADO, RSNA/ACR CDE's (including RadElements and RadLex), and SOLE allow our XStream® aiCockpit® AI viewer technology to communicate and interact with the various AI vendors' algos, AI Orchestrator Systems, Reporting Systems and PACS Archives/Viewers. This demo will show the future of interconnected AI workflows within the radiology ecosystem," stated Fovia Ai's Chief Technology Officer, Kevin Kreeger, Ph.D.

Adjacent to the IAIP demonstration, in the Fovia Ai booth (#4535), attendees can:

To learn more about both Fovia and Fovia Ai's complete product suites or arrange a demonstration at the 107th Scientific Assembly and Annual Meeting of the Radiological Society of North America, November 28 ? December 1, contact us.

About Fovia Ai 

Fovia Ai, Inc. is a subsidiary of Fovia, Inc., a world leader in advanced visualization, a preeminent provider of cloud-based, zero-footprint imaging SDKs, and the developer of High Definition Volume Rendering®, XStream® HDVR® and F.A.S.T.® RapidPrint®. Fovia Ai's flagship products, XStream® aiCockpit® and XStream® aiPlatform® enable radiologists and clinicians to efficiently access AI results directly within their existing workflows from any PACS, worklist, dictation software or hospital system. Complementary products in Fovia Ai's product suite include F.A.S.T.® AI Annotation, F.A.S.T.® AI Validation, F.A.S.T.® AI Workflows, F.A.S.T.® Interactive AI and F.A.S.T.® Interactive Segmentation, collectively providing tools to annotate, validate, modify, accept/reject, interact with and segment data. The flexible architecture of Fovia Ai's product suite and Fovia's nearly two decades of radiology integration experience facilitate seamless integrations with a variety of partners, platforms, processors and operating systems.

For additional information and to learn more about commercial, academic or research licensing, visit fovia.ai or fovia.com.

IMPORTANT REGULATORY NOTICE: The applications mentioned herein are for investigational use only at this time.

SOURCE Fovia Ai, Inc.


These press releases may also interest you

at 00:44
The investment community is moving "up the acuity curve" as they seek novel opportunities to deploy capital, with Cardiology a specialty ripe for consolidation, according to an industry report released by the Healthcare Provider Services investment...

at 00:23
Based on its recent analysis of the global artificial intelligence (AI)-enabled drug discovery industry, Frost & Sullivan recognizes Insilico Medicine...

24 jan 2022
The kidney stones market potential growth difference will be USD 416.09 million from 2021 to 2026, as per the latest market analysis report by Technavio. The market is likely to witness an accelerating momentum at a CAGR of 6.69% during this period....

24 jan 2022
This week, the Foundation for Government Accountability (FGA) released data showing how Medicaid program mismanagement, federal restrictions, and Medicaid expansion have led to significant increases in improper payment rates. With a record-high 89...

24 jan 2022
Yosi Health, a provider of digital patient scheduling, registration, payment, and communication cloud-based software solutions, announced today they have added Hants Williams, PhD, RN, a professor at the State University of New York (SUNY) at Stony...

24 jan 2022
RemeGen Co., Ltd. (9995.HK), a commercial-ready biotechnology company, recently announced positive results from the completion of its Phase II trial in China for Telitacicept in the treatment of primary Sjögren's syndrome ("pSS"). A total of 42...



News published on 28 november 2021 at 10:00 and distributed by: